Diabetic retinopathy
22 results
1 - 22
Semaglutide is not associated with an increased risk of diabetic retinopathy; its risk association with NAION is inconclusive- Tight blood sugar control or fibrates prevent retinopathy progression but not visual loss (ACCORD)
- Fenofibrate reduces laser photocoagulation (FIELD)
- Benefits lacking for tight control of type 2 diabetes
- Intensive glucose lowering does not benefit patients with type 2 diabetes
- In older adults with type 2 diabetes, GLP-1 agonists decrease major adverse cardiovascular events; SGLT2 inhibitors prevent heart failure hospitalizations
- Intensive control of glucose does not improve T2DM outcomes (VADT)
- Meta-analysis: intensive BP control decreases major CV events and stroke, but not MI, CHF, or mortality
- Perindopril+indapamide improves outcomes in high-risk pts with DM (ADVANCE)
- Finerenone reduces composite cardiovascular outcome and risk of decreased eGFR, but increases risk of hyperkalemia
- Semaglutide reduces CV events in high-risk patients with T2DM